Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Am J Ophthalmol. 2017 Apr 4;178:157–162. doi: 10.1016/j.ajo.2017.03.032

Table 1. Baseline Characteristics of Patients by Repeated Culture Results.

Baseline characteristic data for 299 patients with a repeated fungal culture performed 6 days after enrollment in the Mycotic Ulcer Treatment Trial-I. Patient characteristics are stratified by their day-6 culture results.

Baseline Characteristic Fungal Culture Positive on Day 6 (N=92) Fungal Culture Negative on Day 6 (N=207)
Gender, N
Male 43 (14%) 87 (29%)
Female 49 (16%) 120 (40%)
Age (years), median (25th, 75th Percentile) 45 (38, 55) 48 (38,58)
Occupation, N
Agriculture 34 (28%) 100 (33%)
Non-Agriculturea 58 (19%) 107 (36%)
Medication use at enrollmentb, N
Topical ocular antifungals 37 (12%) 101 (34%)
Other topical ocular dropsc 50 (17%) 128 (43%)
Systemic antifungals 1 (1%) 10 (3%)
Other systemic 26 (9%) 54 (18%)
Trauma/Injury, N
Vegetative Matter/Wood 25 (8%) 47 (16% )
Metal/Otherd 33 (11%) 74 (25%)
Unknown Object 3 (1%) 11 (4%)
Contact Lens 0 (0%) 0 (0%)
Affected Eye, N
Right 115 (38%) 40 (13%)
Left 92 (31%) 52 (17%)
Visual Acuity (logMAR), median (25th, 75th percentiles) 0.72 (0.46, 1.02) 0.64 (0.38, 0.88)
Infiltrate/Scar Size (mm1), median (25th, 75th percentiles) 3.39(2.95, 4.08) 3.14(2.40, 3.99)
Hypopyon
no 50 (17%) 147 (49%)
<0.5mm 20 (7%) 32 (11%)
>0.5mm 22 (7%) 28 (9%)
Depth
>0–33% 47 (16%) 111 (37%)
>33–67% 36 (12%) 76 (25%)
>67–100% 9 (3%) 19 (6%)
Epithelial Defect (mm1), median (25th, 75th percentiles) 2.97 (2.00,3.66) 2.30 (1.41,3.39)
Duration of Symptoms, days, median (25th, 75th percentiles) 5 (4,10) 6 (3,10)
Systemic disease, N 9 (3%) 31 (10.4%)
a

Includes unemployed, retired, etc.

b

Some patients were on more than one medication at enrollment

c

Includes topical antibiotics, dilating drops, glaucoma medication, lubricating drops

d

Includes dust, finger, kerosene, cement, fingernail, chili powder, sand, cow’s tail, insect